Skip to main content
Premium Trial:

Request an Annual Quote

Roundtrip from the Dark Side


Doctors-turned-entrepreneur are nothing new, but here’s a twist: an investment manager turned physician turned genomics chief.

Genomics Collaborative’s new CEO, MICHAEL PELLINI, was an analyst with an MBA before going to medical school. Pellini says he got to know Genomics Collaborative’s chairman and founder MICHAEL WALL, who also founded Centocor, while he was practicing medicine as a primary care physician in the Thomas Jefferson Health System in Philadelphia. After a six-month consulting stint, Pellini joined the upstart as vice president of business development in July 1999 and advanced quickly to president and COO before becoming top dog.

The company, which has relationships with Gene Logic, Genometrix, Lynx, and Qiagen, recruits about 6,500 patients per month from around the world for its large-scale genetic association studies.

In the financial sector, Pellini directed a group of investment managers for Mason Lynch in Sydney, where he helped to create a new national standard for asset growth in Australia. Before that, he was a financial consultant with Merrill Lynch.

Genomics Collaborative also named BRENT RICHTER director of bioinformatics, with responsibility for linking genotypic, expression, and proteomic data with its database of medical information, DNA, and tissue samples. Richter had most recently been director of pathoinformatics in the Department of Molecular Biology at Massachusetts General Hospital. There he designed and developed a pathogen-host interactions database with Aventis Research and Technologies.

— Matthew Dougherty

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.